-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Rhythm Pharmaceuticals, Inc. annual/quarterly Amortization of Intangible Assets history and growth rate from Q2 2021 to Q1 2023.
- Rhythm Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2023 was $214K, a 64.6% increase year-over-year.
- Rhythm Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending March 31, 2023 was $858K.
- Rhythm Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $855K, a 10.5% increase from 2022.
- Rhythm Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $774K, a 126% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)